Excretion of indomethacin in breast milk.
- 1 December 1991
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 32 (6) , 751-754
- https://doi.org/10.1111/j.1365-2125.1991.tb03984.x
Abstract
1. The excretion of indomethacin into breast milk and subsequent exposure of infants was studied in 16 women and seven of their infants. The median milk:plasma ratio in seven patients where there were measurable drug concentrations in both milk and plasma was 0.37. 2. Total infant dose, assuming a daily milk intake of 150 ml kg-1 and 100% absorption, ranged from 0.07% to 0.98% (median = 0.18%) of the weight adjusted maternal dose. 3. Plasma samples were obtained in seven infants. In six of these, indomethacin concentrations were below the sensitivity of the assay (less than 20 micrograms l-1), while one infant had a plasma indomethacin concentration of 47 micrograms l-1. 4. No adverse effects due to indomethacin were reported in the infants.This publication has 11 references indexed in Scilit:
- Indomethacin as an analgesic after hysterectomyActa Anaesthesiologica Scandinavica, 1989
- Pharmacokinetics of Postoperative Intravenous Indomethacin in ChildrenBasic & Clinical Pharmacology & Toxicology, 1989
- Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.BMJ, 1988
- The analgesic effect of indomethacin in the early post-operative period following abdominal surgery. A double-blind controlled study.1988
- ANTIRHEUMATIC MEDICATION DURING LACTATIONRheumatology, 1985
- Clinical Pharmacokinetics of IndomethacinClinical Pharmacokinetics, 1981
- Drug Excretion in Human Breast Milk1,2Clinical Pharmacokinetics, 1980
- Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosusEuropean Journal of Clinical Pharmacology, 1980
- CONVULSIONS IN A BREAST-FED INFANT AFTER MATERNAL INDOMETHACINThe Lancet, 1978
- Pharmacokinetics of indomethacinClinical Pharmacology & Therapeutics, 1975